VP20621

· Shire

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VP20621, covering 2015-02-12 to 2015-02-12. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection [Phase 2]